Deutsche Bank Ag\ Supernus Pharmaceuticals, Inc. Transaction History
Deutsche Bank Ag\
- $245 Billion
- Q1 2025
A detailed history of Deutsche Bank Ag\ transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 46,817 shares of SUPN stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,817
Previous 105,583
55.66%
Holding current value
$1.46 Million
Previous $3.82 Million
59.84%
% of portfolio
0.0%
Previous 0.0%
Shares
37 transactions
Others Institutions Holding SUPN
# of Institutions
305Shares Held
60.8MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$324 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.16MShares$192 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$162 Million2.59% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.9MShares$90.5 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$84.1 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.67B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...